Project Details
Description
A 26-Week, Multi-Center, Open-Label, Flexible Dose, Long-Term Safety Trial of Asenapine in Adolescent Subjects with Schizophrenia - Protocol P05897
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/11 → 12/1/13 |
Funding
- SCHERING-PLOUGH CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.